Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Racial and Age-Related Differences in Impacts of High-Risk Cytogenetic Abnormalities on Survival in Multiple Myeloma in a Nationwide Electronic Health Record-Derived Database

Gregory S Calip, Mustafa S Ascha, Xiaoliang Wang, Amy E Pierre, Kathleen Maignan, Niquelle B Wadé, Siyang Leng, Erlene K Seymour, Brian C-H Chiu, Karen Sweiss, Pritesh R Patel, Natalia Neparidze

Blood (2021) 138 (Supplement 1): 4121.

https://doi.org/10.1182/blood-2021-152774

Published: 2021

Journal Articles

Real-World IgG Testing Frequency and Characteristics Associated with Hypogammaglobulinemia after Anti-CD20 Exposure in Patients with Chronic Lymphocytic Leukemia (CLL)

Ian J. Hooley, Kathleen Maignan, NP, Alexandra Jacob, Angelica Medina, MSRA, Lauren Benderoff, Robert Chen, PhD, Scott F. Huntington, MD MPH

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-137094

Published: 2020

Journal Articles

Real-World Outcomes of Patients with Diffuse Large B-Cell Lymphoma Receiving Second Line Therapy in the United States

Ahmed Sawas, MD, Constance Lau, MPH, Michael Thomson, MS, Kathleen Maignan, NP, MSN

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-141274

Published: 2020

Journal Articles

Real-World Application of National Comprehensive Cancer Network (NCCN) Testing Guidelines in Diffuse Large B-Cell Lymphoma (DLBCL) Results in Underdiagnosis of Double-Hit Lymphoma

Ian J. Hooley, BS, Christina M. Parrinello, PhD MPH, Adomah S. Opong, ANP, Kathleen Maignan, NP, MSN, Kenneth R. Carson, MD PhD, Richard I. Fisher, MD

Blood (2019) 134 (Supplement_1): 3426.

https://doi.org/10.1182/blood-2019-127062

Published: 2019

Journal Articles

Cell of Origin (COO) Association with High Body Mass Index (BMI) and Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Kathleen Maignan, NP, MSN, Shaked Peleg Azzam, MA, Blythe Adamson, PhD MPH, Christina M. Parrinello, PhD MPH, Kenneth R. Carson, MD PhD

Blood (2019) 134 (Supplement_1): 4123.

https://doi.org/10.1182/blood-2019-129470

Published: 2019

Journal Articles

Approximating International Myeloma Working Group Uniform Response Criteria to Derive Response for Multiple Myeloma (MM) Patients Using Data from Electronic Health Records (EHR)

Rebekah B. Foster, BA, Max Tromanhauser, BSE, Christopher Gayer, PhD, Patrick K. Gonzales, MS, Kathleen Maignan, NP, Adomah S. Opong, ANP, Aracelis Z. Torres, MPH, PhD, Kenneth R. Carson, MD PhD

Blood (2019) 134 (Supplement_1): 4727.

https://doi.org/10.1182/blood-2019-127181

Published: 2019

Journal Articles

Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy

Ian J Hooley, BS, Robert Chen, PhD, Kathleen Maignan, NP, Kenneth R. Carson, MD PhD

Blood (2018) 132 (Supplement 1): 2249.

https://doi.org/10.1182/blood-2018-99-113636

Published: 2018

Journal Articles

Real-World Disparities in Daratumumab Utilization for Patients with Relapsed or Refractory Multiple Myeloma (MM)

Kathleen Maignan, NP, Daniel Backenroth, Neil A. McQuarrie, Nicole G. Lipitz, Erin R. Williams, Kenneth R. Carson

Blood (2018) 132 (Supplement 1): 4734.

https://doi.org/10.1182/blood-2018-99-112153

Published: 2018

Journal Articles

A Case Series Of Continuous Low Dose Lenalidomide In Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma

Ahmed Sawas, MD, Sean Clark-Garvey, MPH, Ellen Neylon, FNP, MSN, RN, OCN, Ameet Narwal, MPH, Kathleen Maignan, FNP, Emily Lichtenstein, RN, Owen A. O'Connor, MD, PhD

Blood (2013) 122 (21): 5134.

https://doi.org/10.1182/blood.V122.21.5134.5134

Published: 2013

Journal Articles

Results of a Phase II Trial of Oral Bexarotene Combined with Interferon Alfa-2b for Patients with Cutaneous T-Cell Lymphoma (CTCL).

David J. Straus, M.D., Madeleine Duvic, M.D., Timothy Kuzel, M.D., Steven Horwitz, M.D., Marie-France Demierre, M.D., Patricia Myskowski, M.D., Kathleen Maignan, B.A., Steven Steckel, Pharm.D.

Blood (2004) 104 (11): 2644.

https://doi.org/10.1182/blood.V104.11.2644.2644

Published: 2004

NARROW

Racial and Age-Related Differences in Impacts of High-Risk Cytogenetic Abnormalities on Survival in Multiple Myeloma in a Nationwide Electronic Health Record-Derived Database

Real-World IgG Testing Frequency and Characteristics Associated with Hypogammaglobulinemia after Anti-CD20 Exposure in Patients with Chronic Lymphocytic Leukemia (CLL)

Real-World Outcomes of Patients with Diffuse Large B-Cell Lymphoma Receiving Second Line Therapy in the United States

Real-World Application of National Comprehensive Cancer Network (NCCN) Testing Guidelines in Diffuse Large B-Cell Lymphoma (DLBCL) Results in Underdiagnosis of Double-Hit Lymphoma

Cell of Origin (COO) Association with High Body Mass Index (BMI) and Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Approximating International Myeloma Working Group Uniform Response Criteria to Derive Response for Multiple Myeloma (MM) Patients Using Data from Electronic Health Records (EHR)

Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy

Real-World Disparities in Daratumumab Utilization for Patients with Relapsed or Refractory Multiple Myeloma (MM)

A Case Series Of Continuous Low Dose Lenalidomide In Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma

Results of a Phase II Trial of Oral Bexarotene Combined with Interferon Alfa-2b for Patients with Cutaneous T-Cell Lymphoma (CTCL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only